senate Bill S4515

Provides for the use of glucagon emergency injection kits by persons other than licensed health care professionals

download pdf

Sponsor

Co-Sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 05 / Apr / 2013
    • REFERRED TO HEALTH
  • 10 / Jun / 2013
    • 1ST REPORT CAL.1167
  • 11 / Jun / 2013
    • 2ND REPORT CAL.
  • 12 / Jun / 2013
    • ADVANCED TO THIRD READING
  • 13 / Jun / 2013
    • PASSED SENATE
  • 13 / Jun / 2013
    • DELIVERED TO ASSEMBLY
  • 13 / Jun / 2013
    • REFERRED TO HEALTH
  • 08 / Jan / 2014
    • DIED IN ASSEMBLY
  • 08 / Jan / 2014
    • RETURNED TO SENATE
  • 08 / Jan / 2014
    • REFERRED TO HEALTH

Summary

Provides for the use of glucagon emergency injection kits by persons other than licensed health care professionals; provides for expanded use of epinephrine auto-injector devices in schools in emergency circumstances.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A7041
Versions:
S4515
Legislative Cycle:
2013-2014
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Amd §§3000-a & 3000-c, add §3000-e, Pub Health L

Sponsor Memo

BILL NUMBER:S4515

TITLE OF BILL: An act to amend the public health law, in relation to
use of epinephrine auto-injector devices in schools and authorizing
the use of glucagon for emergency injection kits

PURPOSE: To permit the use of glucagon emergency injection kits, in
addition to epi-pens, by personnel trained in the use of these devices
who have a collaborative agreement with a physician or a hospital.

SUMMARY OF PROVISIONS: Section one amends Subdivision 2 of Section
3000-a of the Public Health Law adding the use of glucagon emergency
injection kits to the good samaritan protections under Section 3000-a
of the Public Health Law.

Section two amends Section 3000-c of the Public Health Law by adding a
school district or any designated school district employee as an
eligible person or organization that may possess and use epinephrine
auto-injector devices or glucagon emergency injection kits. Said
eligibility is contingent on the individual or entity completing
appropriate training and having a collaborative agreement with a
physician or hospital.

Section three adds a new paragraph (d) to Subdivision 3 of Section
3000-c of the Public Health Law. Paragraph (d) states that any school
district that designates a person or persons to possess and use
epinephrine auto-injector devices or glucagon emergency injection kits
to notify the Commissioner of Education and ensure that those named
complete the required training.

Section four adds a new Section 3000-e to the Public Health Law
setting out the specifics of the glucagon emergency injection kits.
In this section, eligible persons and organizations are defined, and
emergency health care provider is also defined. The section also
establishes the collaborative agreement procedures, and it sets the
limits of how and when glucagon emergency injection kits may be Used.
The last part of this section provides for the application of this
legislation in regard to other pertinent laws.

Section five states that this legislation shall take effect
immediately.

JUSTIFICATION: For persons with diabetes, the availability of
glucagon for emergency injection kits can be a matter of life and
death. Individuals with diabetes receive a prescription for glucagon
and are told by their doctors to always carry it with them. Although
persons with known cases of diabetes carry glucagon on their person,
they may sometimes find themselves without it. Moreover, in rare
instances persons with unknown cases of diabetes may suffer
hypoglycemia and need immediate glucagon to prevent diabetic shock,
which could lead to death.

In 1999 New York State adopted legislation to permit the use of
epi-pens (emergency injection kits for those suffering a severe
allergic reaction) by personnel trained in the use of the devices who
have collaboration agreement with a physician or hospital. Glucagon
injections are very similar to epi-pens in that they provide emergency


assistance to those suffering a potentially fatal health episode. This
legislation builds upon the 1999 statute by providing similar
authorization and good samaritan protections for the use of Glucagon
emergency injection kits.

This bill helps to ensure that life saving measures will be taken for
diabetics in need who are past the point of being able to help
themselves. By adding glucagon for emergency injection kit to the good
samaritan protections, any liability concerns that may hinder someone
from coming to the aid of an individual in need of a glucagon
injection are alleviated. This legislation helps make glucagon for
emergency injection kits available in settings such as summer camps
and schools while maintaining appropriate medical oversight and
patient protections.

LEGISLATIVE HISTORY: Passed Senate in 2005 as S 2559

FISCAL IMPLICATIONS: None.

EFFECTIVE DATE: Immediately.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  4515

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                              April 5, 2013
                               ___________

Introduced  by  Sen.  HANNON -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to use of epinephrine
  auto-injector devices in schools and authorizing the use  of  glucagon
  for emergency injection kits

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Subdivision 2 of section 3000-a of the public  health  law,
as  amended  by  chapter  243 of the laws of 2010, is amended to read as
follows:
  2. (i) Any person who, or entity, partnership,  corporation,  firm  or
society  that,  purchases, operates, facilitates implementation or makes
available resuscitation equipment that facilitates first aid,  an  auto-
mated  external  defibrillator [or], an epinephrine auto-injector device
OR A GLUCAGON EMERGENCY INJECTION KIT as required by or pursuant to  law
or local law, or (ii) an emergency health care provider under a collabo-
rative  agreement  pursuant  to section three thousand-b of this article
with respect to an automated external defibrillator, or (iii) the  emer-
gency  health care provider with a collaborative agreement under section
three thousand-c of this article with respect to use of  an  epinephrine
auto-injector  device, OR (IV) THE EMERGENCY HEALTH CARE PROVIDER WITH A
COLLABORATIVE AGREEMENT UNDER SECTION THREE THOUSAND-E OF  THIS  ARTICLE
WITH  RESPECT TO USE OF A GLUCAGON EMERGENCY INJECTION KIT, shall not be
liable for damages arising either from the use of that  equipment  by  a
person  who voluntarily and without expectation of monetary compensation
renders first aid or emergency treatment at the scene of an accident  or
medical  emergency,  or  from the use of defectively manufactured equip-
ment; provided that this subdivision shall not  limit  the  person's  or
entity's,  partnership's,  corporation's, firm's, society's or the emer-
gency health care provider's liability for his, her or  its  own  negli-
gence, gross negligence or intentional misconduct.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10175-01-3

S. 4515                             2

  S  2.  Paragraph  (a) of subdivision 1 of section 3000-c of the public
health law, as amended by chapter 350 of the laws of 2001, is amended to
read as follows:
  (a)  "Eligible person, firm, organization, or other entity" means, (i)
an ambulance service or advanced life support first response service;  a
certified  first  responder,  emergency  medical technician, or advanced
emergency medical technician, who is employed by or an  enrolled  member
of  any  such  service;  (ii)  a children's overnight camp as defined in
subdivision one of section thirteen hundred ninety-two of this  chapter,
a  summer  day  camp  as  defined in subdivision two of section thirteen
hundred ninety-two of this chapter,  a  traveling  summer  day  camp  as
defined  in  subdivision three of section thirteen hundred ninety-two of
this chapter or a person employed by such a camp; [or] (iii)  any  other
person,  firm, organization or entity designated pursuant to regulations
of the commissioner in consultation with other appropriate agencies;  OR
(IV)  A  SCHOOL DISTRICT OR ANY PERSON EMPLOYED BY A SCHOOL DISTRICT WHO
IS DESIGNATED AS SUCH; and all subject to regulations of the commission-
er.
  S 3. Subdivision 3 of section 3000-c  of  the  public  health  law  is
amended by adding a new paragraph (d) to read as follows:
  (D)  EVERY SCHOOL DISTRICT THAT DESIGNATES ANY PERSON OR PERSONS AS AN
ELIGIBLE PERSON SHALL IMMEDIATELY NOTIFY THE COMMISSIONER  OF  EDUCATION
AND  ENSURE  THAT ALL SUCH PERSONS IMMEDIATELY SUCCESSFULLY COMPLETE THE
TRAINING REQUIRED BY PARAGRAPH (A) OF THIS SUBDIVISION.
  S 4. The public health law is amended by adding a new  section  3000-e
to read as follows:
  S  3000-E.  GLUCAGON EMERGENCY INJECTION KITS. 1. DEFINITIONS. AS USED
IN THIS SECTION:
  (A) "ELIGIBLE PERSON, FIRM, ORGANIZATION, OR OTHER ENTITY" MEANS,  (I)
AN  AMBULANCE SERVICE OR ADVANCED LIFE SUPPORT FIRST RESPONSE SERVICE; A
CERTIFIED FIRST RESPONDER, EMERGENCY  MEDICAL  TECHNICIAN,  OR  ADVANCED
EMERGENCY  MEDICAL  TECHNICIAN, WHO IS EMPLOYED BY OR AN ENROLLED MEMBER
OF ANY SUCH SERVICE; (II) A CHILDREN'S  OVERNIGHT  CAMP  AS  DEFINED  IN
SUBDIVISION  ONE OF SECTION THIRTEEN HUNDRED NINETY-TWO OF THIS CHAPTER,
A SUMMER DAY CAMP AS DEFINED IN  SUBDIVISION  TWO  OF  SECTION  THIRTEEN
HUNDRED  NINETY-TWO  OF  THIS  CHAPTER,  A  TRAVELING SUMMER DAY CAMP AS
DEFINED IN SUBDIVISION THREE OF SECTION THIRTEEN HUNDRED  NINETY-TWO  OF
THIS  CHAPTER  OR  A  PERSON  EMPLOYED  BY  SUCH A CAMP; (III) ANY OTHER
PERSON, FIRM, ORGANIZATION OR ENTITY DESIGNATED PURSUANT TO  REGULATIONS
OF  THE COMMISSIONER IN CONSULTATION WITH OTHER APPROPRIATE AGENCIES; OR
(IV) A SCHOOL DISTRICT OR ANY PERSON EMPLOYED BY A SCHOOL  DISTRICT  WHO
IS DESIGNATED AS SUCH; AND ALL SUBJECT TO REGULATIONS OF THE COMMISSION-
ER.
  (B)  "EMERGENCY HEALTH CARE PROVIDER" MEANS (I) A PHYSICIAN WITH KNOW-
LEDGE AND EXPERIENCE IN THE DELIVERY OF EMERGENCY CARE; OR (II) A HOSPI-
TAL LICENSED UNDER ARTICLE TWENTY-EIGHT OF THIS  CHAPTER  THAT  PROVIDES
EMERGENCY CARE.
  2. COLLABORATIVE AGREEMENT. ANY ELIGIBLE PERSON, FIRM, ORGANIZATION OR
OTHER  ENTITY  MAY PURCHASE, ACQUIRE, POSSESS AND USE GLUCAGON FOR EMER-
GENCY INJECTION KITS PURSUANT TO A COLLABORATIVE AGREEMENT WITH AN EMER-
GENCY HEALTH CARE PROVIDER. THE COLLABORATIVE AGREEMENT SHALL INCLUDE  A
WRITTEN  AGREEMENT  THAT  INCORPORATES  WRITTEN  PRACTICE PROTOCOLS, AND
POLICIES AND PROCEDURES THAT SHALL ENSURE COMPLIANCE WITH THE PROVISIONS
OF THIS SECTION. THE PERSON, FIRM, ORGANIZATION OR ENTITY SHALL  FILE  A
COPY  OF THE COLLABORATIVE AGREEMENT WITH THE DEPARTMENT AND WITH APPRO-

S. 4515                             3

PRIATE REGIONAL COUNCIL  PRIOR  TO  USING  ANY  GLUCAGON  FOR  EMERGENCY
INJECTION KITS.
  3. POSSESSION AND USE OF GLUCAGON EMERGENCY INJECTION KITS. POSSESSION
AND  USE  OF  GLUCAGON  EMERGENCY  INJECTION  KITS  SHALL  BE LIMITED AS
FOLLOWS:
  (A) NO PERSON SHALL USE A GLUCAGON EMERGENCY INJECTION KIT UNLESS SUCH
PERSON SHALL HAVE SUCCESSFULLY COMPLETED A TRAINING COURSE IN THE USE OF
GLUCAGON EMERGENCY INJECTION KITS APPROVED BY THE COMMISSIONER  PURSUANT
TO  THE  RULES  OF  THE  DEPARTMENT. THIS SECTION SHALL NOT BE DEEMED TO
PROHIBIT THE USE OF A GLUCAGON EMERGENCY INJECTION KIT (I) BY  A  HEALTH
CARE  PRACTITIONER LICENSED OR CERTIFIED UNDER TITLE EIGHT OF THE EDUCA-
TION LAW ACTING WITHIN THE SCOPE OF HIS OR HER PRACTICE, OR  (II)  BY  A
PERSON ACTING PURSUANT TO A LAWFUL PRESCRIPTION.
  (B)  EVERY PERSON, FIRM, ORGANIZATION AND ENTITY AUTHORIZED TO POSSESS
AND USE GLUCAGON EMERGENCY INJECTION KITS PURSUANT TO THIS SECTION SHALL
USE, MAINTAIN AND DISPOSE OF SUCH KITS PURSUANT TO  REGULATIONS  OF  THE
DEPARTMENT.
  (C)  EVERY  USE OF A GLUCAGON EMERGENCY INJECTION KIT PURSUANT TO THIS
SECTION SHALL IMMEDIATELY BE  REPORTED  TO  THE  EMERGENCY  HEALTH  CARE
PROVIDER.
  (D)  EVERY SCHOOL DISTRICT THAT DESIGNATES ANY PERSON OR PERSONS AS AN
ELIGIBLE PERSON SHALL IMMEDIATELY NOTIFY THE COMMISSIONER  OF  EDUCATION
AND ENSURE THAT ALL PERSONS IMMEDIATELY SUCCESSFULLY COMPLETE THE TRAIN-
ING REQUIRED BY PARAGRAPH (A) OF THIS SUBDIVISION.
  4.  APPLICATION  OF  OTHER  LAWS.  (A)  USE  OF  A  GLUCAGON EMERGENCY
INJECTION KIT PURSUANT TO THIS SECTION SHALL BE CONSIDERED FIRST AID  OR
EMERGENCY  TREATMENT  FOR THE PURPOSE OF ANY STATUTE RELATING TO LIABIL-
ITY.
  (B) PURCHASE, ACQUISITION, POSSESSION OR USE OF A  GLUCAGON  EMERGENCY
INJECTION KIT PURSUANT TO THIS SECTION SHALL NOT CONSTITUTE THE UNLAWFUL
PRACTICE  OF  A  PROFESSION  OR OTHER VIOLATION UNDER TITLE EIGHT OF THE
EDUCATION LAW OR ARTICLE THIRTY-THREE OF THIS CHAPTER.
  (C) ANY PERSON OTHERWISE AUTHORIZED TO SELL OR PROVIDE A GLUCAGON  FOR
EMERGENCY INJECTION KIT MAY SELL OR PROVIDE IT TO A PERSON AUTHORIZED TO
POSSESS IT PURSUANT TO THIS SECTION.
  S 5. This act shall take effect immediately.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.